Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study

BACKGROUND: Prostate-specific antigen (PSA) testing is limited in identifying prostate cancer (PCa) with modestly elevated PSA levels. Therefore, a robust method for the diagnosis of PCa is urgently needed. METHODS: A total of 203 men with a PSA level of ≥4 ng/ml were eligible for enrollment in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhenrong, Bai, Hongsong, Hu, Linjun, Kong, Defeng, Li, Guoliang, Zhao, Changyun, Feng, Lin, Cheng, Shujun, Shou, Jianzhong, Zhang, Wen, Zhang, Kaitai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808177/
https://www.ncbi.nlm.nih.gov/pubmed/35128360
http://dx.doi.org/10.1016/j.eclinm.2021.101161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808177/
https://www.ncbi.nlm.nih.gov/pubmed/35128360
http://dx.doi.org/10.1016/j.eclinm.2021.101161

Ejemplares similares